Cargando…
Detection of EpCAM-Negative and Cytokeratin-Negative Circulating Tumor Cells in Peripheral Blood
Enrichment of rare circulating tumor cells (CTCs) in blood is typically achieved using antibodies to epithelial cell adhesion molecule (EpCAM), with detection using cytokeratin (CK) antibodies. However, EpCAM and CK are not expressed in some tumors and can be downregulated during epithelial-to-mesen...
Autores principales: | Mikolajczyk, Stephen D., Millar, Lisa S., Tsinberg, Pavel, Coutts, Stephen M., Zomorrodi, Maryam, Pham, Tam, Bischoff, Farideh Z., Pircher, Tony J. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3090615/ https://www.ncbi.nlm.nih.gov/pubmed/21577258 http://dx.doi.org/10.1155/2011/252361 |
Ejemplares similares
-
The detection of EpCAM(+) and EpCAM(–) circulating tumor cells
por: Wit, Sanne de, et al.
Publicado: (2015) -
EpCAM(high) and EpCAM(low) circulating tumor cells in metastatic prostate and breast cancer patients
por: de Wit, Sanne, et al.
Publicado: (2018) -
Expression of EpCAM(MF) and EpCAM(MT) variants in human carcinomas
por: Fong, Dominic, et al.
Publicado: (2014) -
Detection of circulating tumor cells in blood of metastatic breast cancer patients using a combination of cytokeratin and EpCAM antibodies
por: Weissenstein, Ulrike, et al.
Publicado: (2012) -
EpCAM expression negatively regulates E-cadherin function in colorectal carcinomas
por: Ezenkwa, Uchenna Simon, et al.
Publicado: (2023)